NPCE
Neuropace Inc
14.50$
+1.8%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 3.33 | 3.71 | 2.72 | 1.85 | 2.53 | 2.74 | 3.06 | |
| 0.95 | 0.98 | 0.71 | 0.53 | 0.67 | 0.71 | 0.70 | |
| 2.38 | 2.73 | 2.01 | 1.32 | 1.86 | 2.03 | 2.36 | |
| 1.65 | 1.41 | 1.10 | 0.89 | 0.80 | 0.81 | 0.85 | |
| 2.72 | 2.49 | 2.35 | 2.09 | 2.11 | 0.60 | 0.58 | |
| 4.37 | 3.90 | 3.44 | 2.98 | 2.91 | 2.77 | 2.86 | |
| -1.98 | -1.18 | -1.43 | -1.66 | -1.05 | -0.74 | -0.50 | |
| 0.85 | 1.03 | 0.45 | 0.31 | 0.33 | 0.30 | 0.23 | |
| -2.70 | -2.19 | -2.17 | -1.91 | -1.27 | -0.93 | -0.66 | |
| 0.97 | 1.05 | 0.12 | 0.26 | 0.06 | – | – | |
| -2.70 | -2.19 | -2.17 | -1.91 | -1.27 | -0.93 | -0.66 | |
| -1.81 | -1.12 | -1.71 | -1.49 | -0.88 | -0.57 | -0.37 |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.